Israel-Based IM Cannabis Continues Canadian Expansion With $67.6M MYM Nutraceuticals Acquisition

Multi-country medical and recreational cannabis operator, IM Cannabis (CSE: IMCC) (NASDAQ: IMCC) continues to strategically expand in with its second acquisition of 2021.

The company announced this week it reached a definitive agreement to acquire MYM Nutraceuticals and its Licensed Producer subsidiary Highland Growth.

The acquisition is expected to close before the end of 2021 and is valued at C$85 million ($67.6 …

Full story available on Benzinga.com

More Israel-Based IM Cannabis Continues Canadian Expansion With $67.6M MYM Nutraceuticals Acquisition